Who
John Richard Sylvester
Director
Company insider
Files Form 4 as: Director, Delcath Systems.
In numbers
- Trades disclosed
- 10
- Buys
- 2
- Sells
- 0
- Bought
- $90K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 23 Nov 2020
- Last trade
- 13 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 May 2026filed 14 May 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 21 Nov 2025filed 25 Nov 2025 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Bought | $39K4,386 at $8.89 | filing |
| 15 May 2025filed 19 May 2025 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 21 Aug 2023filed 23 Aug 2023 | DCTH Delcath SystemsMedical Devices | SEC FORM 4 Bought | $51K10,550 at $4.80 | filing |
| 12 Jun 2023filed 22 Jun 2023 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —19,682 at $0.00 | filing |
| 4 May 2022filed 6 May 2022 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 5 Aug 2021filed 9 Aug 2021 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 23 Nov 2020filed 25 Nov 2020 | DCTH Delcath Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
Delcath Systems, Inc.: Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal MelanomaDCTH · finanznachrichten.de · 19 Oct 2026Head-To-Head Analysis: Delcath Systems (NASDAQ:DCTH) & Neogen (NASDAQ:NEOG)DCTH · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name John Richard Sylvester; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.